Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer

Gland Surgery ◽

10.21037/gs-20-571 ◽

2021 ◽

Vol 10 (1) ◽

pp. 154-165

Author(s):

Lan Le ◽

Yoshihisa Tokumaru ◽

Masanori Oshi ◽

Mariko Asaoka ◽

Li Yan ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Chemotherapy Response ◽

Th2 Cell ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Estrogen receptor positive breast cancer identified by 95-gene classifier as at high risk for relapse shows better response to neoadjuvant chemotherapy

Cancer Letters ◽

10.1016/j.canlet.2012.04.017 ◽

2012 ◽

Vol 324 (1) ◽

pp. 42-47 ◽

Author(s):

Ryo Tsunashima ◽

Yasuto Naoi ◽

Kazuki Kishi ◽

Yosuke Baba ◽

Atsushi Shimomura ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Neoadjuvant Chemotherapy ◽

Estrogen Receptor Positive ◽

Response To Neoadjuvant Chemotherapy ◽

Positive Breast Cancer

Download Full-text

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2013.00317 ◽

2013 ◽

Vol 3 ◽

Author(s):

David M. Marcus ◽

Jeffrey M. Switchenko ◽

Roshan Prabhu ◽

Ruth O’Regan ◽

Amelia Zelnak ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Hormonal Therapy ◽

Neoadjuvant Hormonal Therapy ◽

Menopausal Women ◽

Estrogen Receptor Positive ◽

Post Menopausal ◽

Positive Breast Cancer

Download Full-text

Neoadjuvant chemotherapy with or without the concurrent hormone therapy that has downregulated estrogen level in estrogen receptor positive breast cancer: NACED randomized multicenter phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e11501 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e11501-e11501 ◽

Author(s):

Naoki Watanabe ◽

Takayuki Iwamoto ◽

Takayuki Motoki ◽

Kumi Sugiu ◽

Masako Omori ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Hormone Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Estrogen Level ◽

Multicenter Phase ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e11506 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e11506-e11506

Author(s):

Halle C. F. Moore ◽

Baidehi Maiti ◽

Lisa A. Rybicki ◽

Christine Booth ◽

Jame Abraham ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Predictors Of Response ◽

Estrogen Receptor Positive ◽

Response To Neoadjuvant Chemotherapy ◽

Positive Breast Cancer

Download Full-text

Measurement of molecular biomarkers to predict tumor response in estrogen receptor positive breast cancer after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdw364.46 ◽

2016 ◽

Vol 27 ◽

pp. vi56

Author(s):

K. Wang ◽

T. Zhu ◽

C. Yang ◽

Y. Zhang ◽

L. Zhang

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Tumor Response ◽

Molecular Biomarkers ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer

Breast Cancer ◽

10.1007/s12282-013-0482-2 ◽

2013 ◽

Vol 22 (3) ◽

pp. 308-316 ◽

Author(s):

Mai Kawase ◽

Tatsuya Toyama ◽

Satoru Takahashi ◽

Shinya Sato ◽

Nobuyasu Yoshimoto ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Prognostic Marker ◽

Estrogen Receptor Positive ◽

Foxa1 Expression ◽

Positive Breast Cancer

Download Full-text

Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor‐positive breast cancer patients

Journal of Surgical Oncology ◽

10.1002/jso.26096 ◽

2020 ◽

Author(s):

Michael R. Boland ◽

Éanna J. Ryan ◽

Timothy Nugent ◽

Darina Gilroy ◽

Michael E. Kelly ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Progesterone Receptor ◽

Cancer Patients ◽

Progesterone Receptor Status ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive ◽

Response To Neoadjuvant Chemotherapy ◽

Positive Breast Cancer

Download Full-text

A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer

10.18632/oncotarget.13549 ◽

2016 ◽

Vol 7 (52) ◽

pp. 87312-87322 ◽

Author(s):

Weige Tan ◽

Wei Luo ◽

Weijuan Jia ◽

Gehao Liang ◽

Xinhua Xie ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Pathological Complete Response ◽

Prognostic Index ◽

Complete Response ◽

Nottingham Prognostic Index ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737201214.793572775 ◽

2020 ◽

Author(s):

Vijay Tiwari ◽

Deborah Lavin

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Therapeutic Response ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Reverse effect of chidamide on endocrine resistance in estrogen receptor-positive breast cancer

JOURNAL OF SHENZHEN UNIVERSITY SCIENCE AND ENGINEERING ◽

10.3724/sp.j.1249.2018.04339 ◽

2018 ◽

Vol 35 (4) ◽

pp. 339 ◽

Author(s):

You ZHOU ◽

Yan'an WANG ◽

Kun ZHANG ◽

Jingzhong ZHU ◽

Zhiqiang NING

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Resistance ◽

Reverse Effect ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text